Abstract
Pretargeting imaging has gained a lot of prominence, due to its excellent bioorthogonality and improved imaging contrast compared to conventional imaging. A new iodo tetrazine (Tz) derivative has been synthesized and further developed into the corresponding iodine-125 ( 125 I) analog (12), via the trimethylstannane precursor. Radiolabeling with either N-chlorosuccinimide or chloramine-T, in either MeCN or MeOH proceeded with a radiochemical conversion (RCC) of >80%. Subsequent deprotection only proved successful, among the tested conditions, when the radiolabeled Tz was stirred in 6-M HCl (aq.) at 60°C for 2.5 h. To the best of our knowledge, this is the first H-tetrazine labeled with iodine. In vivo investigations on the pretargeting ability of 12 are currently under way.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Labelled Compounds and Radiopharmaceuticals |
Vol/bind | 66 |
Udgave nummer | 1 |
Sider (fra-til) | 22-30 |
ISSN | 0362-4803 |
DOI | |
Status | Udgivet - 2023 |